1 Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
2 School of Medicine, Department of Pediatrics and Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
J Aerosol Med Pulm Drug Deliv. 2019 Feb;32(1):47-53. doi: 10.1089/jamp.2017.1442. Epub 2018 Oct 30.
Electronic cigarettes (ECIGs) are widely used, but their health effects are not well known. ECIG exposure is difficult to quantify, and a direct measurement of deposition would be beneficial to in vivo and in vitro toxicity studies. The aim of this study was to demonstrate effective radiolabeling of an ECIG.
A technetium-99m-labeled carbon ultrafine (TCU) aerosol was generated and introduced to a fourth-generation ECIG before nucleation and aerosol formation. The aerosolized e-liquid was a commercially available strawberry flavor containing 1.2% nicotine in a 55% propylene glycol and 45% vegetable glycerine base. An ECIG power setting of 100 W was selected. Mass and radioactivity were measured on each stage within a Sierra Cascade Impactor at 14 L/min to verify the labeling technique using the calculated aerodynamic diameters. A strong positive correlation (R > 0.95) between the percent activity and percent mass deposition on each stage provides a reliable validation of colocation.
Unlabeled ECIG aerosol from the chosen e-liquid produced a mass median aerodynamic diameter (MMAD) of 0.85 μm. An ECIG labeled with TCU produced an aerosol with an activity median aerodynamic diameter of 0.84 μm and an MMAD of 0.84 μm. The relative mass versus radioactivity on each plate was highly correlated (average R = 0.973, p < 0.001).
A TCU radiolabel was generated and shown to associate with the mass of an aerosol produced by a typical commercially available ECIG. Thus, the radioactivity of the deposited aerosol may be used to determine ECIG aerosol deposition for the future in vivo and in vitro dosimetry studies of the third- and fourth-generation ECIGs.
电子烟(ECIG)被广泛使用,但它们的健康影响尚不清楚。ECIG 的暴露很难量化,直接测量沉积量将有助于体内和体外毒性研究。本研究旨在证明一种 ECIG 的有效放射性标记。
生成锝-99m 标记的碳超细(TCU)气溶胶,并在成核和气溶胶形成之前引入第四代 ECIG。气溶胶化的电子液体是一种市售的草莓味液体,含有 1.2%尼古丁,55%丙二醇和 45%植物甘油基。选择 100 W 的 ECIG 功率设置。在 14 L/min 的 Sierra Cascade Impactor 内的每个阶段测量质量和放射性,以使用计算的空气动力学直径验证标记技术。每个阶段的活性百分比和质量沉积百分比之间存在很强的正相关性(R>0.95),这为共定位提供了可靠的验证。
所选电子液体的未标记 ECIG 气溶胶产生的质量中值空气动力学直径(MMAD)为 0.85μm。用 TCU 标记的 ECIG 产生的气溶胶的活性中值空气动力学直径为 0.84μm,MMAD 为 0.84μm。每个板上的相对质量与放射性高度相关(平均 R=0.973,p<0.001)。
生成了 TCU 放射性标记物,并证明它与典型市售 ECIG 产生的气溶胶的质量相关联。因此,沉积气溶胶的放射性可用于确定未来第三代和第四代 ECIG 的体内和体外剂量学研究中的 ECIG 气溶胶沉积。